CTOs on the Move

Oregon Freeze Dry

www.ofd.com

 
Oregon Freeze Dry, Inc. has a firm policy to produce only high quality food products in the cleanest, most modern food processing plant. Our facilities are USDA and FDA approved and are continuously inspected. We use the highest quality meat, poultry,
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.ofd.com
  • 525 25th Ave SW
    Albany, OR USA 97322
  • Phone: 541.926.6001

Executives

Name Title Contact Details

Similar Companies

Medsource RX

Medsource RX is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Suvoda

Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management. Suvoda’s Interactive Response Technology (IRT/IWRS) combines the flexibility of a custom solution with the speed of a configurable platform, offering 4-week deployment, reimagined reporting, and easy integration.

Service Drug Company

Service Drug Company is a Delta, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunovion Pharmaceuticals

Sunovion Pharmaceuticals is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IntelGenx

IntelGenx is a Montreal based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery. Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy. IntelGenx is capable, through itself and strategic partners, of offering its partners full service pharmaceutical development from formulation development, clinical development and regulatory activities to manufacturing and packaging. IntelGenx’s highly qualified team has the capability to work with new chemical entities (NCEs) or established therapeutic active pharmaceutical ingredients (APIs) where the use of innovative new drug delivery systems offer significant competitive advantage or the opportunity for product extension and life cycle management.